StockData
Trulieve Cannabis Corp. logo

Trulieve Cannabis Corp. (TRLV) stock

TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3033% below fair value
$10.33−0.57 (-5.23%)

Close on Nov 16, 2026Market cap $1.99BP/E –Yield –

Trulieve Cannabis total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Trulieve Cannabis's total debt was $89.39M at Jun 30, 2026. For fiscal 2025 it was $90.84M, down 18.9% from the year before. The highest annual figure on record is $115.86M in fiscal 2023.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$90.84M-18.9%
FY2024Dec 31, 2024$111.95M-3.4%
FY2023Dec 31, 2023$115.86M+22.9%
FY2022Dec 31, 2022$94.25M+1359.8%
FY2021Dec 31, 2021$6.46M+61.4%
FY2020Dec 31, 2020$4.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$89.39M-17.6%
Q1 FY2026Mar 31, 2026$90.10M-18.9%
Q4 FY2025Dec 31, 2025$90.84M-18.9%
Q3 FY2025Sep 30, 2025$107.67M-4.5%
Q2 FY2025Jun 30, 2025$108.52M-4.4%
Q1 FY2025Mar 31, 2025$111.14M-3.4%
Q4 FY2024Dec 31, 2024$111.95M-3.4%
Q3 FY2024Sep 30, 2024$112.76M+22.2%
Q2 FY2024Jun 30, 2024$113.51M+22.1%
Q1 FY2024Mar 31, 2024$115.01M+23.0%
Q4 FY2023Dec 31, 2023$115.86M+22.9%
Q3 FY2023Sep 30, 2023$92.31M+1062.3%
Q2 FY2023Jun 30, 2023$92.96M+2606.2%
Q1 FY2023Mar 31, 2023$93.52M+1648.1%
Q4 FY2022Dec 31, 2022$94.25M+1359.8%
Q3 FY2022Sep 30, 2022$7.94M+495.8%
Q2 FY2022Jun 30, 2022$3.44M-14.1%
Q1 FY2022Mar 31, 2022$5.35M+33.7%
Q4 FY2021Dec 31, 2021$6.46M–
Q2 FY2021Jun 30, 2021$1.33M–
Q1 FY2021Mar 31, 2021$4.00M–
Q4 FY2020Dec 31, 2020$4.00M–

More Trulieve Cannabis figures

See a number that looks wrong?